Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at … Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Post-Market 0.05 (1.25%) In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. A high-level overview of Antares Pharma, Inc. (ATRS) stock. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. The company’s stock price has collected 15.32% of gains in the last five trading sessions. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Provided by GlobeNewswire Sep 8, 2020 12:00 PM UTC Sponsor Center We started the process of determining a valid price forecast for Antares Pharma Inc … One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. Shares of Antares Pharma, Inc. (NASDAQ:ATRS) have received an average recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. The company was founded in 1979 and is based in Ewing, New Jersey. Recently in News on November 23, 2020, Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. The average 12 month target price among brokerages that […] Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Lgbt Scholarships Canada 2021, Brockhampton New Album Technical Difficulties, Cebu Institute Of Technology Tuition Fee, Burma After Independence, Capella University Lawsuit, Veterans For Peace In Vietnam, 6 Week Crossfit Results,